Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析

◆英語タイトル:Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amarin Corp Plc (AMRN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amarin Corp Plc (Amarin) is a pharmaceutical company which develops and commercializes medicines for cardiovascular diseases. The company’s lead product, Vascepa (icosapent ethyl), is a single-molecule prescription capsule used as an adjunct to diet for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia andcardiovascular risk. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has operations in Ireland, the US, Germany, Switzerland, the Uk, Italy, France and Israel. Amarin is headquartered at Dublin, Ireland.

Amarin Corp Plc Key Recent Developments

Feb 25,2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17,2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07,2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30,2020: Amarin files patent infringement lawsuit against Hikma
Nov 05,2020: Amarin reports third quarter 2020 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amarin Corp Plc – Key Facts
Amarin Corp Plc – Key Employees
Amarin Corp Plc – Key Employee Biographies
Amarin Corp Plc – Major Products and Services
Amarin Corp Plc – History
Amarin Corp Plc – Company Statement
Amarin Corp Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amarin Corp Plc – Business Description
Product Category: Licensing Revenue
Overview
Performance
Product Category: Vascepa
Overview
Performance
R&D Overview
Amarin Corp Plc – SWOT Analysis
SWOT Analysis – Overview
Amarin Corp Plc – Strengths
Amarin Corp Plc – Weaknesses
Amarin Corp Plc – Opportunities
Amarin Corp Plc – Threats
Amarin Corp Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17, 2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07, 2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30, 2020: Amarin files patent infringement lawsuit against Hikma
Nov 05, 2020: Amarin reports third quarter 2020 financial results and provides business update
Aug 04, 2020: Amarin reports second quarter 2020 financial results and provides update on operations
Apr 30, 2020: Amarin reports first quarter 2020 financial results and provides update on operations
Apr 28, 2020: Amarin to Report First Quarter 2020 Results and Host Conference Call on April 30, 2020
Feb 25, 2020: Amarin reports record fourth quarter and full year 2019 financial results and provides update on operations
Jan 13, 2020: Amarin launches true to your heart, a campaign to educate people on persistent cardiovascular risk
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amarin Corp Plc, Key Facts
Amarin Corp Plc, Key Employees
Amarin Corp Plc, Key Employee Biographies
Amarin Corp Plc, Major Products and Services
Amarin Corp Plc, History
Amarin Corp Plc, Subsidiaries
Amarin Corp Plc, Key Competitors
Amarin Corp Plc, Ratios based on current share price
Amarin Corp Plc, Annual Ratios
Amarin Corp Plc, Annual Ratios (Cont...1)
Amarin Corp Plc, Interim Ratios
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務情報
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Full House Resorts, Inc.:企業の戦略・SWOT・財務情報
    Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Western Gas Partners LP (WES):企業の財務・戦略的SWOT分析
    Summary Western Gas Partners LP (Western Gas), a subsidiary of Anadarko Petroleum Corp is an oil and gas company that acquires, owns, develops and operates midstream energy assets. The company's services include processing, compressing, gathering, treating and transporting natural gas, natural gas l …
  • IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • CSG Systems International Inc (CSGS):企業の財務・戦略的SWOT分析
    CSG Systems International Inc (CSGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chattem Inc:企業の戦略・SWOT・財務情報
    Chattem Inc - Strategy, SWOT and Corporate Finance Report Summary Chattem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Shimano Inc. (7309):企業の財務・戦略的SWOT分析
    Shimano Inc. (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Australian Broadcasting Corp:企業の戦略的SWOT分析
    Australian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • Chr. Hansen Holding A/S:企業の戦略・SWOT・財務分析
    Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pon Holdings BV:企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • PT Paninvest Tbk:企業の戦略・SWOT・財務情報
    PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kate Spade & Company LLC:企業の戦略・SWOT・財務分析
    Kate Spade & Company LLC - Strategy, SWOT and Corporate Finance Report Summary Kate Spade & Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • IntraPace Inc-医療機器分野:企業M&A・提携分析
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company provides abiliti systems that contains sensors intended to track consumption events and physical activity using this information to direct when therapy is delivered and to monitor a pat …
  • Newmont Corp:企業の戦略・SWOT・財務分析
    Newmont Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Gencor Nutrients, Inc.:企業の戦略・SWOT・財務情報
    Gencor Nutrients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gencor Nutrients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aeras Global TB Vaccine Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aeras Global TB Vaccine Foundation Inc (Aeras) is a non-profit biotech organization that develops tuberculosis (TB) vaccines. The organization offers TB vaccine candidates, preclinical candidates and vaccine candidates. Its services include portfolio management, preclinical research, clinica …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆